Werdegang von Pedro Enrique Schuermann aus Oberursel (Taunus): Geschäftsführer der ProtaGene GmbH, Geschäftsführer der PGN Holding GmbH

Information on valuation, funding, acquisitions, investors, and executives for ProtaGene. Use the PitchBook Platform to explore the full profile.

Company relations and network for Pedro Enrique Schuermann, Oberursel (Taunus), Germany: previously ProtaGene GmbH

View the executive profile of Pedro Schuermann, Chief Financial Officer at Protagen Protein Services, on Equilar ExecAtlas to see current and past work history and gain access to Pedro Schuermann's network of 4 business contacts.

ProtaGene is a world-leading CRO partner for the biopharmaceutical and gene and cell therapy industries.

The Leadership Team at ProtaGene is responsible for steering the company's strategic direction and operational execution. This includes scientific oversight, business development, quality assurance, and multi-site management, ensuring that ProtaGene's analytic services meet the highest standards in the biopharmaceutical and gene therapy sectors.

View Pedro Schuermann business profile as Chief Financial Officer at ProtaGene. Find contact's direct phone number, email address, work history, and more.

ProtaGene is a world-leading CRO partner for the biopharmaceutical and gene and cell therapy industries. From research through product commercialization, we provide the most advanced, integrated, and complete protein and gene analytic capabilities and packages for biologic therapeutics as well as gene and cell therapy platforms.

Nov 20, 2023 · Heilbronn & Heidelberg, Germany and Boston, USA – November 20th, 2023 — ProtaGene, a leading global contract research organization (CRO) dedicated to advanced analytics for biologics and cell and gene therapies, today announced additional investment from Ampersand Capital Partners.